Nonclinical Biostatistics Working Group

Nonclinical Biostatistics Manufacturing Comparability CMC Scientific Working Group

About this workstream

Chair: Aili Cheng (Pfizer)

The Manufacturing Comparability workstream was established in 2023 with the aim of providing guidance on statistical approaches, design, and criteria for analytical and method comparability studies. The workstream falls under the umbrella of the ASA Biopharmaceutical Nonclinical Working Group (NCBWG), which includes several industry and academia members who form small sub-teams to work on specific projects.

 

How to get involved

If you are interested in staying up to date with the workstream progress on projects identified below, please contact the chair to be added to our email list. There is no obligation to participate beyond being a member of the email list.

If you may be interested in volunteering to help with team efforts, please contact the chair or someone else in the current team membership below to discuss your interests.

 

Current Projects

Project

Contributors

Write a manuscript on Statistical Methods for Analytical Comparability between Pre-change and Post-change Processes

Aili Cheng (Pfizer)

Bill Pikounis (JnJ)

Irina Gershgorin (Novartis)

José Ramirez (Kite)

Sayli Pokal (Zoetis)

Stone Wang (Novartis)

 

Write a manuscript on Statistical Methods for Method Comparability and Applications using JMP.

José Ramirez (Kite)

Aili Cheng (Pfizer)

Bill Pikounis (JnJ)

Irina Gershgorin (Novartis)

Sayli Pokal (Zoetis)

Stone Wang (Novartis)

 

 

Upcoming Forums

Leaders

Sep 26 2024 Roundtable at Regulatory-Industry-Workshop (RIW)

“Analytical Comparability for Cell & Gene Therapies”

Check https://ww2.amstat.org/meetings/biop/2024/roundtables.cfm when program is published.

Aili Cheng (Pfizer)